Changes in the clinical manifestations of primary aldosteronism

Korean Journal of Internal Medicine

Volumn 29, Issue 2, 2014, Pages 217-225

  Kim, Sun Hwa ^a   Ahn, Jae Hee ^a   Hong, Ho Cheol ^a   Choi, Hae Yoon ^a   Kim, Yoon Jung ^a   Kim, Nam Hoon ^a   Yoo, Hye Jin ^a   Kim, Hee Young ^a   Seo, Ji A ^a   Kim, Nan Hee ^a   Kim, Sin Gon ^a   Choi, Kyung Mook ^a   Baik, Sei Hyun ^a   Choi, Dong Seop ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Hyperaldosteronism; Hypertension; Hypokalemia

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID ANTAGONIST; POTASSIUM ION; BIOLOGICAL MARKER; POTASSIUM;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; IDIOPATHIC DISEASE; IDIOPATHIC HYPERALDOSTERONISM; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; SCREENING TEST; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; TREATMENT OUTCOME; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND; ADRENOCORTICAL ADENOMA; BLOOD; COMPARATIVE STUDY; HYPERKALEMIA; HYPERPLASIA; MIDDLE AGED; PREDICTIVE VALUE; RADIOGRAPHY; RISK FACTOR; SOUTH KOREA; TIME;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENOCORTICAL ADENOMA; ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERKALEMIA; HYPERPLASIA; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; PREDICTIVE VALUE OF TESTS; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84897853025     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.2.217     Document Type: Article

References (25)

1. Kim SW. Primary aldosteronism. Korean J Med 2012;82:396-402.
2. Fishman LM, Kuchel O, Liddle GW, Michelakis AM, Gordon RD, Chick WT. Incidence of primary aldosteronism uncomplicated "essential" hypertension: a prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 1968;205:497-502.
3. Kaplan NM. Commentary on incidence of primary aldosteronism: current estimations based on objective data. Arch Intern Med 1969;123:152-154.
4. Fagugli RM, Taglioni C. Changes in the perceived epidemiology of primary hyperaldosteronism. Int J Hypertens 2011;2011:162804.
5. Young WF Jr. Minireview: primary aldosteronism: changing concepts in diagnosis and treatment. Endocrinology 2003;144:2208-2213.
6. Acelajado MC, Calhoun DA. Resistant hypertension, secondary hypertension, and hypertensive crises: diagnostic evaluation and treatment. Cardiol Clin 2010;28:639-654.
7. Park J, Kim DJ, Yang SJ, et al. Comparison of target organ damages between primary aldosteronism and essential hypertension. J Korean Endocr Soc 2007;22:11-18.
8. Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007;50:911-918.
9. Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996;27:1039-1045.
10. Conn JW. Presidential address: I. painting background: II. primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955;45:3-17.
11. Young WF Jr. Pheochromocytoma and primary aldosteronism. Cancer Treat Res 1997;89:239-261.
12. Gordon RD. Primary aldosteronism: actual epidemics or false alarm? Arq Bras Endocrinol Metabol 2004;48:666-673.
13. Kaplan NM. Cautions over the current epidemic of primary aldosteronism. Lancet 2001;357:953-954.
14. Kaplan NM. The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 2004;22:863-869.
15. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-3281.
16. Rossi GP. New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Curr Hypertens Rep 2007;9:90-97.
17. Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293-2300.
18. Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl 1987;5:S103-S106.
19. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004;136:1227-1235.
20. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-484.
21. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996;131:646-650.
22. Baer L, Sommers SC, Krakoff LR, Newton MA, Laragh JH. Pseudo-primary aldosteronism: an entity distinct from true primary aldosteronism. Circ Res 1970;27(1 Suppl 1):203-220.
23. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2003;14(9 Pt 2):S477-S492.
24. Rossi GP, Sacchetto A, Pavan E, et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997;95:1471-1478.
25. Rossi GP, Di Bello V, Ganzaroli C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002;40:23-27.